CN103849638A - Plasmid vector for constructing and screening cDNA (complementary deoxyribonucleic acid) library and construction method and application of plasmid vector - Google Patents
Plasmid vector for constructing and screening cDNA (complementary deoxyribonucleic acid) library and construction method and application of plasmid vector Download PDFInfo
- Publication number
- CN103849638A CN103849638A CN201410058679.XA CN201410058679A CN103849638A CN 103849638 A CN103849638 A CN 103849638A CN 201410058679 A CN201410058679 A CN 201410058679A CN 103849638 A CN103849638 A CN 103849638A
- Authority
- CN
- China
- Prior art keywords
- ppr3
- vector
- gateway
- ccdb
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002299 complementary DNA Substances 0.000 title claims abstract description 49
- 238000010276 construction Methods 0.000 title claims abstract description 28
- 238000012216 screening Methods 0.000 title claims abstract description 26
- 239000013600 plasmid vector Substances 0.000 title claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 239000013598 vector Substances 0.000 claims abstract description 22
- 239000013612 plasmid Substances 0.000 claims abstract description 18
- 238000001086 yeast two-hybrid system Methods 0.000 claims abstract description 17
- 238000005516 engineering process Methods 0.000 claims abstract description 7
- 238000010367 cloning Methods 0.000 claims abstract description 5
- 238000012163 sequencing technique Methods 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 101150102092 ccdB gene Proteins 0.000 claims description 10
- 238000001962 electrophoresis Methods 0.000 claims description 10
- 108091008146 restriction endonucleases Proteins 0.000 claims description 5
- 230000004083 survival effect Effects 0.000 claims description 4
- 108700005090 Lethal Genes Proteins 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 18
- 108090000848 Ubiquitin Proteins 0.000 abstract description 3
- 102000044159 Ubiquitin Human genes 0.000 abstract description 3
- 230000003993 interaction Effects 0.000 abstract description 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract 3
- 102000018697 Membrane Proteins Human genes 0.000 abstract 3
- 238000001976 enzyme digestion Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 238000001556 precipitation Methods 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 239000012634 fragment Substances 0.000 description 13
- 238000005406 washing Methods 0.000 description 11
- 230000008569 process Effects 0.000 description 7
- 230000005611 electricity Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 208000009842 photoparoxysmal response 3 Diseases 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010381 tandem affinity purification Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides a plasmid vector for constructing and screening a cDNA (complementary deoxyribonucleic acid) library and a construction method and application of the plasmid vector. The most effective method for the interaction of a membrane protein and a host is the utilization of a ubiquitin-mediated membrane protein yeast two-hybrid system, and a convenient and rapid method for the construction of the cDNA library is a Gateway-based efficient library construction system. The membrane protein yeast two-hybrid system is fused with the Gateway system, a vector pPR3-N is used as a template, and an attR1-Cmr-ccdB-attR2 gene is introduced in an enzyme digestion connection way to transform a pPR3-gateway vector plasmid capable of efficiently constructing the cDNA library by using a Gateway technology, and the pPR3-gateway vector plasmid is used for the directional cloning, library construction and sequencing of full-length cDNA, or is used for the library screening of yeast two-hybrid.
Description
Technical field
The invention belongs to gene engineering technology field, relate in particular to a kind of plasmid vector and construction process and application that builds screening for cDNA library.
Background technology
Proteomics research has been widely used in multiple systematic researches of doing mutually, comprise that virus studies with the mutual of host cell, and research method is also more and more diversified, common method mainly contains yeast two-hybrid, total length infectious clone, tandem affinity purification and bimolecular fluorescence complementary etc.For the membranin of encoding viral or the albumen of film correlation properties, owing to thering is film binding characteristic, mutual mostly occurring on film in vivo, traditional yeast two-hybrid system occurs in core, although added nuclear localization signal peptide on the carrier of test kit, gene all can be anchored in yeast core, but with cell in the situation of doing mutually under state of nature or discrepant, and posttranslational modification process etc. all cannot complete.Embrane-associated protein accounts for 1/3 in total cellular protein, and they have mostly participated in many physiology, pathologic process and the disease resistance response mechanism of cell.The interaction of research membranin has important meaning for disclosing the vital movement rule of cell and finding action target.For study the interactional needs of membranin in viable cell, successively develop the new system of a series of yeast two-hybrids for membranin repercussion study in the world in recent years, and obtained many important discoveries at medical field.There is at present the ubiquitin yeast two-hybrid system that is specially adapted for membranin, directly in film system, occurred to do mutually, solved these difficult problems.But membranin yeast two-hybrid system must be bought corresponding library or customization, cost is higher, and program complexity.
Summary of the invention
The object of the present invention is to provide a kind of plasmid vector that builds screening for cDNA library, be intended to Gateway technique to high-efficiency construction cDNA library plasmid, can transformed yeast, for membranin yeast two-hybrid.
A further object of the present invention is to provide the above-mentioned construction process that builds the plasmid vector of screening for cDNA library.
Another object of the present invention is to provide the above-mentioned application that builds the plasmid vector of screening for cDNA library.
The present invention is achieved in that a kind of plasmid vector that can be used for construction cDNA library screening, by pPR3-N carrier and attR1-Cm
r-ccdB-attR2 genomic constitution, is designated as pPR3-gateway carrier, wherein, described attR1 sequence as shown in SEQ ID NO.1, described Cm
rsequence is as shown in SEQ ID NO.2, and described ccdB sequence is as shown in SEQ ID NO.3, and described attR2 sequence is as shown in SEQ ID NO.4.
Preferably, described attR1-Cm
r5 ' end of-ccdB-attR2 gene is connected with pPR3-N carrier through SfiI digestion with restriction enzyme respectively with 3 ' end.
Preferably, described attR1-Cm
r-ccdB-attR2 gene is the sequence between the upper attR1 of carrier pDEST22 and attR2.
The construction process that the present invention further provides a kind of plasmid vector that can be used for construction cDNA library screening, comprises the following steps:
(1) for primers attR1sfiA and attR2sfiB between the upper attR1 of carrier pDEST22 and attR2, choose pPR3-N carrier universal sequencing primer thing pPR3-NF and pPR3-NR; Wherein, primer attR1sfiA and attR2sfiB sequence are as follows:
attR1sfiA:
5’-agtggccattacggccACAAGTTTGTACAAAAAAGCTGAACGAGAAACG-3’,
attR2sfiB:
5’-agaggccgaggcggccACCACTTTGTACAAGAAAGCTGAACGA-3’;
PPR3-NF and pPR3-NR primer sequence are as follows:
pPR3-NF:5’GTCGAAAATTCAAGACAAGG3’,
pPR3-NR:5’AAGCGTGACATAACTAATTAC3’;
(2) extension increasing sequence: take the DNA sequence dna of carrier pDEST22 as template, increase and obtain attR1-Cm with primer attR1sfiA and attR2sfiB
r-ccdB-attR2 gene;
(3) build plasmid: with SfiI restriction enzyme respectively enzyme cut carrier pPR3-N and attR1-Cm
r-ccdB-attR2 gene order, electrophoresis electrophoresis runs glue and reclaims, and connects and obtains pPR3-gateway carrier; By described pPR3-gateway carrier conversion ccdB survival strain competent cell, on the LB flat board containing Amp and Cm, obtain restructuring bacterium colony, check order and identify with primer pPR3-NF and pPR3-N amplification; Described pPR3-gateway carrier is transformed to DH5 α competent cell, identify lethal gene ccdB expression according to transformant production.
The present invention further provides the application of the above-mentioned plasmid vector that can be used for construction cDNA library screening, described pPR3-gateway carrier is for carrying the object carrier of goal gene by Gateway technique construction.
Preferably, described Gateway technology comprises the following steps:
A, goal gene is carried out to BP reaction, be building up on pDONOR221 carrier;
B, described pDONOR221 carrier and pPR3-gateway carrier are carried out to LR react, goal gene is fused on pPR3-gateway carrier, build the object carrier that obtains pPR3-gateway and carry goal gene.
The present invention further provides the application of the above-mentioned plasmid vector that can be used for construction cDNA library screening, above-mentioned pPR3-gateway carrier is for directed cloning, library construction and the order-checking of full-length cDNA, or for the library screening of yeast two-hybrid.
The present invention overcomes the deficiencies in the prior art, a kind of plasmid vector and construction process and application that can be used for construction cDNA library screening is provided, in the present invention, it is the membranin yeast two-hybrid system that utilizes ubiquitin mediation that membranin and host make effective means mutually, and the comparatively simple and efficient method in the construction cDNA library efficient library construction system that is Gateway.The present invention, by membranin yeast two-hybrid system and Gateway system are merged mutually, take carrier pPR3-N as template, cuts the method for connection and introduces attR1-Cm with enzyme
r-ccdB-attR2 gene, be transformed into the pPR3-gateway vector plasmid in available Gateway technique to high-efficiency construction cDNA library, this pPR3-gateway carrier is for directed cloning, library construction and the order-checking of full-length cDNA, or for the library screening of yeast two-hybrid.
Accompanying drawing explanation
Fig. 1 is the plasmid map of pDEST22 carrier in the embodiment of the present invention 1;
Fig. 2 is that in the embodiment of the present invention 1, pPR3-Gateway(is pPR3-N-R1R2) plasmid map of carrier;
Fig. 3 is the structure schematic diagram of pPR3-Gateway carrier in the embodiment of the present invention 1;
Fig. 4 is that in the embodiment of the present invention 1, pPR3-N enzyme is cut product and Insert Fragment PCR product electrophorogram;
Fig. 5 is that the embodiment of the present invention 3 middle plateforms are identified storage capacity spirogram;
Fig. 6 is the embodiment of the present invention 3 Chinese library Insert Fragment qualification result schematic diagram.
Embodiment
In order to make object of the present invention, technical scheme and advantage clearer, below in conjunction with drawings and Examples, the present invention is further elaborated.Should be appreciated that specific embodiment described herein, only in order to explain the present invention, is not intended to limit the present invention.
The efficient yeast vector of embodiment 1 builds
1, design of primers
As shown in Figure 1, according to plasmid map design primer attR1sfiA and the attR2sfiB of pDEST22 carrier, primer sequence is as follows for the plasmid map of pDEST22 carrier:
attR1sfiA:
5’-agtggccattacggccACAAGTTTGTACAAAAAAGCTGAACGAGAAACG-3’,
attR2sfiB:
5’-agaggccgaggcggccACCACTTTGTACAAGAAAGCTGAACGA-3’;
AttR1sfiA and attR2sfiB primer 5 ' end band SfiI restriction enzyme site,
According to upper two SfiI that intermediate sequence is different of pPR3-N, called after SfiA and SfiB respectively.
The exactness of identifying Insert Fragment sequence with pPR3-N carrier universal sequencing primer thing pPR3-NF and pPR3-NR order-checking, wherein, pPR3-NF and pPR3-NR primer sequence are as follows:
pPR3-NF:5’-GTCGAAAATTCAAGACAAGG-3’,
pPR3-NR:5’-AAGCGTGACATAACTAATTAC-3’。
2, goal gene fragment clone
Amplify the sequence (attR1-Cm between attR1 and attR2 by attR1sfiA and attR2sfiB primer from pDEST22 plasmid vector
r-ccdB-attR2)
PCR reaction system:
On Thermal Cycler PCR instrument, carry out PCR reaction by following condition.
1%Agarose gel electrophoresis is identified order-checking, wherein, attR1 end primer band SfiA, attR2 end band SfiB, attR1 sequence as shown in SEQ ID NO.1, described Cm
rsequence is as shown in SEQ ID NO.2, and described ccdB sequence is as shown in SEQ ID NO.3, and described attR2 sequence is as shown in SEQ ID NO.4.
3, the structure of PR3-Gateway plasmid vector
As shown in Figure 3, Fig. 3 is the structure schematic diagram of PR3-Gateway carrier, specifically comprises:
(1) cut after the PCR product (attR1-Cmr-ccdB-attR2) that pPR3-N and above primer expand by SfiI enzyme; electrophoresis run glue reclaim, electrophoresis result as shown in Figure 4, wherein; swimming lane MW molecular weight standard, swimming lane 1~2 is cut product fragment electrophoresis result for pPR3-NSfiI enzyme; Swimming lane 3~4 Insert Fragments (attR1-Cmr-ccdB-attR2) electrophoresis result.
Endonuclease reaction system:
(2) carry out ligation, ligation system:
16 ℃ of connections are spent the night, and obtain PR3-Gateway carrier, as shown in Figure 2, this PR3-Gateway carrier are transformed to ccdB survival strain competent cell.Conversion process is as follows:
A, will connect product, all be added in 100 μ l competent cells ice bath 30min;
B, heat shock 60 seconds in 42 ℃ of water-baths, transfer to cooled on ice 2min immediately;
C, add LB nutrient solution (every liter containing 10gTryptone, 5g Yeast Extract, 10g NaCl, pH7.0) the 890 μ L of ice precooling, 37 ℃ of shaking table low speed (<200rm) are cultivated 1h;
D, get 100 μ l and coat the LB flat board containing Amp and Cm, 37 ℃ of incubated overnight (10-14h).
4, plasmid identification
Carrier transformed bacteria liquid (ccdB survival strain) is coated on the LB flat board containing Amp and Cm, if normal growth shows that Insert Fragment is normal; Correct cloned plasmids transforms DH5 α competent cell, produces without transformant, shows lethal gene in Insert Fragment (ccdB) normal expression.
According to Gateway clone technology carrier construction, use Auele Specific Primer from genome or the carrier that contains object fragment, amplification object segment, PCR product electrophoresis is confirmed after band, with QIAquick Gel Extraction Kit(Qiagen) cut glue recovery, then use
bP ClonaseII Enzyme Mix(Invitrogen) carry out BP reaction, be building up on pDONOR221 carrier.
BP reaction system is as follows:
In centrifuge tube, add att-PCR product | 1.5ul |
PDONOR221 carrier | 0.5ul |
BP ClonaseII Enzyme Mix | 0.5ul |
Mix, 25 ℃ are incubated 1 hour, then add the Proteinase K of 0.5ul2ug/ul, hatch 10min for 37 ℃.Thermal shock transforms intestinal bacteria, the screening of Kan+ microbiotic plate, and picking mono-clonal, shakes bacterium, and upgrading grain, sends to order-checking.After order-checking is correct, enzyme is cut, and linear carrier is reclaimed in rubber tapping, then uses
lR ClonaseII Enzyme Mix(Invitrogen) carry out LR reaction, be fused in pPR3-Gateway terminals and go.
LR reaction system is as follows:
In centrifuge tube, add linear carrier | 1.5ul |
PPR3-Gateway carrier | 0.5ul |
LR ClonaseII Enzyme Mix | 0.5ul |
Mix, 25 ℃ are incubated 1 hour, then add the Proteinase K of 0.5ul2ug/ul, hatch 10min for 37 ℃.Thermal shock transforms intestinal bacteria, microbiotic plate screening (determining according to concrete carrier), and picking mono-clonal, shakes bacterium, upgrading grain, sequence verification exactness.
The efficient yeast two-hybrid library construction of embodiment 3
1, the extraction of TotalRNA
Carry out with reference to Trizol specification sheets.Get 100mg tissue sample, use liquid nitrogen grinding powder in the mortar of precooling, then proceed in 1.5ml centrifuge tube, add the Trizol reagent of 1ml, vibration mixes, and room temperature leaves standstill the abundant lysing cell of 10min; Add the chloroform of 200ul, concuss 15sec, room temperature leaves standstill 5min; At 4 ℃, 12,000 × g high speed frozen centrifugation 15min; Get supernatant in new 1.5ml centrifuge tube, add 0.5ml Virahol, put upside down and mix, room temperature leaves standstill 10min; At 4 ℃, 12,000 × g high speed frozen centrifugation 10min; Remove supernatant, add the 75% washing with alcohol precipitation of 1ml, 7,500 × g high speed frozen centrifugation 5min(repeats this step once); Remove supernatant, air drying RNA precipitation, is then dissolved in 50ulDEPC water.
2, the separation of mRNA
(1) by the Total RNA precipitation of > 500ug, be resuspended in the DEPC water of 100ul.
(2) get new 50ml centrifuge tube, add the Stock Buffer of 10ml and the ProteinaseK of 200ul, form the Lysis Buffer that mRNA separates, then the Total RNA of upper step is added in Lysis Buffer, put upside down and mix.
(3) 65 ℃ of water-bath 5min, then put 1min on ice immediately.
(4) add the 5MNaCl of 650ul, put upside down and mix.
(5) get a pipe oligo(dT) cellulose, add in above-mentioned buffer, put upside down and mix 2min.
(6) 50ml centrifuge tube is placed in to mixed at room temperature 60min on mixed instrument.
(7) room temperature, the centrifugal 5min of 3,000 × g, removes supernatant.
(8) add the Binding Buffer of 20ml, resuspended precipitation, room temperature, the centrifugal 5min of 3,000 × g, removes supernatant.
(9) add the Binding Buffer of 10ml, resuspended precipitation, room temperature, the centrifugal 5min of 3,000 × g, removes supernatant.
(10) add the Low Salt Wash Buffer of 10ml, resuspended precipitation, room temperature, the centrifugal 5min of 3,000 × g, removes supernatant; Repeat this step 4 time.
(11) precipitation is resuspended in to the Low Salt Wash Buffer of 800ul, and forwards in spin-column, then spin-column is placed in to collection tube, room temperature, the centrifugal 10sec of 5000 × g, removes filtered solution
(12) add the Low Salt Wash Buffer washing precipitation of 500ul, room temperature, the centrifugal 10sec of 5000 × g, removes filtered solution; Repeat this step 4 time.
(13) spin-column is placed in to new 2ml centrifuge tube, adds the Elution Buffer of 200ul, abundant resuspended precipitation, room temperature, the centrifugal 30sec of 5000 × g, must guard against and do not remove elutriant; Add again the Elution Buffer of 200ul, abundant resuspended precipitation, room temperature, the centrifugal 30sec of 5000 × g, obtains two parts of 400ul elutriants altogether.
(14) add the 2M sodium acetate of 60ul, and 1ml dehydrated alcohol, put upside down and mix, be placed in-80 ℃ of 15min.
(15), at 4 ℃, 14000rpm high speed frozen centrifugation 15min, removes supernatant.
(16) 75% washing with alcohol precipitations, 4 ℃, 14000rpm high speed frozen centrifugation 10min, removes supernatant.
(17) in air, dry precipitation, be finally dissolved in the DEPC water of 50ul, be placed in-80 ℃ of preservations.
3, the structure of cDNA library (Uncut type)
Carry out with reference to CloneMiner specification sheets.
(1) cDNA the first chain is synthetic
A gets the mRNA3ug obtaining in step, is dissolved in 9ulDEPC water;
B adds biotin-attB2-Oligo(dT) Primer(30pmol) 1ul, and 10mM(each) dNTPs1ul, 65 ℃ of 5min, cool to 45 ℃, 2min;
C adds 5X First Strand Buffer4ul, DTT(0.1M) 2ul, 45 ℃, 2min;
D adds SuperScript III RT enzyme 3ul, 45 ℃, 60min.
(2) cDNA the second chain is synthetic
A according to the form below in above-mentioned reaction solution adds each composition:
16 ℃, 2 hours;
B adds T4DNA Polymerase2ul, and 16 ℃, 5min;
C adds 0.5M EDTA(pH8.0) 10ul;
D adds phenol: chloroform: primary isoamyl alcohol (25:24:1) 160ul, fully mixes 30sec; 14000rpm, the centrifugal 5min of room temperature, is carefully taken into supernatant in new centrifuge tube;
E according to the form below adds each composition:
Glycogen(20ug/ul) 1ul
7.5M NH
4OAc 80ul
100%ethanol 600ul
-80 ℃, leave standstill 15min; 14000rpm, 4 ℃, centrifugal 25min, removes supernatant;
F adds 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant;
G adds 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant;
H room temperature 5-10min dries cDNA;
I blows and beats 30-40 time repeatedly with the DEPC water of 18ul, dissolves cDNA.
(3) cDNA is connected (three kinds of respectively each connections of joint are a) with three frame attB1 restructuring joints
Mix latter 16 ℃, 16-24 hour.
(4) cDNA fractional separation and collection
Fixing fractionation column, opens upper cover, then opens stopper below.Treat that in pillar, storage liquid is flow to end, add 0.8mlTEN Buffer clean pillar, determine pillar flow velocity be every 30~40 seconds one, every 25~35ul, otherwise the fractionation column that need to more renew (repeating this step 3 time); Be ready to 20 new 1.5ml centrifuge tubes, mark 1~20; The cDNA product of three parts of each 50ul is mixed and added in pillar, collect and filter product in No. 1 pipe; Again to the TEN Buffer that adds 50ul in pillar, collect and filter product and manage with No. 2; At every turn, to the TEN Buffer that adds 100ul in pillar, collect 1 filtration product since No. 3 every pipes of pipe; The cDNA output of collecting with the every pipe of spectrophotometric determination, with the pipettor cDNA volume that accurately definite every pipe is collected, the cDNA product that before merging, 150ng collects.
According to the form below adds each composition:
Glycogen(20ug/ul) 1ul
7.5M NH
4OAc 0.5V
100%ethanol 2.5V
-80 ℃, leave standstill 15min; 14000rpm, 4 ℃, centrifugal 25min, removes supernatant; Add 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant; Add 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant; Room temperature 5~10min dries Cdna; Repeatedly blow and beat 30~40 times with the DEPC water of 9ul, dissolve cDNA.
(5) BP recombining reaction
According to the form below adds each composition:
Mix and be placed on 25 ℃, 16~20 hours.
(6) electricity transforms intestinal bacteria DH10B
In BP recombining reaction system, add the ProreinaseK of 2ul, 37 ℃, 15min; 75 ℃, 10min, according to the form below adds each composition:
-80 ℃, leave standstill 15min; 14000rpm, 4 ℃, centrifugal 25min, removes supernatant; Add 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant; Add 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant; Room temperature 5~10min dries cDNA; Repeatedly blow and beat 30~40 times with the TE Buffer of 8ul, dissolve cDNA; First by the revolving cup-80 ℃ precooling of 1mm electricity, on ice, 2ul recombinant products and 50ul electricity are turned to competent cell DH10B and add electric revolving cup, put 45min on ice; After electric shock, in electric revolving cup, add SOC substratum 1ml rapidly; Point is turned to thing and be taken into new 15ml centrifuge tube, be placed in 37 ℃, 225~250rpm shaking table is cultivated 1 hour; After cultivation finishes, identify for storage capacity according to 2.4.1 method spread plate; Residue culture adds glycerine to final concentration 20% to be stored in-80 ℃, and this is library bacterium liquid.
(7) cDNA library (Uncut type) library quality evalution
The evaluation of A storage capacity
Get transform after after 1000 times of bacterium stoste (1ml) 10ul dilutions, therefrom take out 50ul coating LB flat board (containing corresponding resistant), second day counting.
Clone number/50ul × 1000 on total clone's number CFU=flat board times × 1 × 10
3ul
B recombination fraction and Insert Fragment length are identified
Random 24 clones of picking carry out bacterium colony PCR evaluation
In Microtube, be formulated as follows reaction solution:
On Thermal Cycler PCR instrument, carry out PCR reaction by following condition.
1%Agarose gel electrophoresis is identified.
4, the plasmid extraction in Uncut library
Upper step is demonstrate,proved to qualified Uncut library, adopt broth culture, shake bacterium, 30 ℃ of incubated overnight, took out plasmid in second day, and plasmid is surveyed OD electrophoresis detection.
5, library plasmid restructuring
By in take out the plasmid obtaining, be diluted to 300ng/ul, according to following Establishing LR recombining reaction, according to the form below adds each composition:
Mix and be placed on 25 ℃, 16~20 hours, 2.6.3 electricity transformed intestinal bacteria DH10B.In LR recombining reaction system, add the ProreinaseK of 2ul, 37 ℃, 15min; 75 ℃, 10min, according to the form below adds each composition:
-80 ℃, leave standstill 15min; 14000rpm, 4 ℃, centrifugal 25min, removes supernatant; Add 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant; Add 150ul70% washing with alcohol precipitation; 14000rpm, 4 ℃, centrifugal 3min, removes supernatant; Room temperature 5~10min dries Cdna; Repeatedly blow and beat 30~40 times with the TEBuffer of 8ul, dissolve cDNA; First by the revolving cup-80 ℃ precooling of 1mm electricity, on ice, 2ul recombinant products and 50ul electricity are turned to competent cell DH10B and add electric revolving cup, put 45min on ice; After electric shock, in electric revolving cup, add SOC substratum 1ml rapidly; Point is turned to thing and be taken into new 15ml centrifuge tube, be placed in 37 ℃, 225~250rpm shaking table is cultivated 1 hour; After cultivation finishes, identify for storage capacity according to 2.4.1 method spread plate; Residue culture adds glycerine to final concentration 20% to be stored in-80 ℃, and this is library bacterium liquid.
6, Yeast two-hybrid cDNA library quality evalution
(1) evaluation of storage capacity
Get transform after after 1000 times of bacterium stoste (1ml) 10ul dilutions, therefrom take out 50ul coating LB flat board (containing corresponding resistant), second day counting, as shown in Figure 5, Fig. 5 is plate assay storage capacity spirogram.
Clone number/50ul × 1000 on total clone's number CFU=flat board times × 1 × 10
3ul.
Clone number/0.5ul × 1000 on flat board times=850/0.5ul × 1000 times=1.7 × 10
6cfu/ml
Total clone number CFU=1.7 × 10
6cfu/ml × 4ml=0.68 × 10
7.
(2) recombination fraction and Insert Fragment length are identified
Random 36 clones of picking carry out bacterium colony PCR evaluation
In Microtube, be formulated as follows reaction solution:
On Thermal Cycler PCR instrument, carry out PCR reaction by following condition:
The evaluation of 1%Agarose gel electrophoresis, as shown in Figure 6, Fig. 6 is library Insert Fragment qualification result schematic diagram; Wherein, M:1kb DNA ladder; Swimming lane 1~32 is cDNA Insert Fragment.
Compare and the shortcoming and defect of prior art, the present invention has following beneficial effect: the present invention obtains the gateway carrier of an efficient quick, can be used for directed cloning, library construction and the order-checking of full-length cDNA; Be a Yeast expression carrier simultaneously, can be used as the plasmid in the screening library of yeast two-hybrid.
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, all any modifications of doing within the spirit and principles in the present invention, be equal to and replace and improvement etc., within all should being included in protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410058679.XA CN103849638A (en) | 2014-02-21 | 2014-02-21 | Plasmid vector for constructing and screening cDNA (complementary deoxyribonucleic acid) library and construction method and application of plasmid vector |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410058679.XA CN103849638A (en) | 2014-02-21 | 2014-02-21 | Plasmid vector for constructing and screening cDNA (complementary deoxyribonucleic acid) library and construction method and application of plasmid vector |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103849638A true CN103849638A (en) | 2014-06-11 |
Family
ID=50857761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410058679.XA Pending CN103849638A (en) | 2014-02-21 | 2014-02-21 | Plasmid vector for constructing and screening cDNA (complementary deoxyribonucleic acid) library and construction method and application of plasmid vector |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103849638A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745609A (en) * | 2015-03-20 | 2015-07-01 | 河南大学 | Method for high-flux rapidly cloning of rape draught-resistant gene |
CN109680344A (en) * | 2018-12-19 | 2019-04-26 | 塔里木大学 | A kind of sheepskin skin tissue yeast cDNA library and its construction method |
CN110396515A (en) * | 2018-04-24 | 2019-11-01 | 上海欧易生物医学科技有限公司 | A kind of membranous system expression library reducing library redundancy and its construction method and application |
CN114990105A (en) * | 2022-06-09 | 2022-09-02 | 南京瑞源生物技术有限公司 | Yeast membrane library construction method based on plant sample |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010029353A (en) * | 1999-09-30 | 2001-04-06 | 최의주 | Rat SKIP protein and gene as a selective inhibitor of SAPK and as an apoptotic suppressor |
US6492138B1 (en) * | 1998-05-21 | 2002-12-10 | Amgen Canada Inc. | Polynucleotides encoding a novel SHC-binding protein |
CN102061307A (en) * | 2010-11-23 | 2011-05-18 | 上海交通大学 | Construction method of yeast two-hybrid plasmids |
-
2014
- 2014-02-21 CN CN201410058679.XA patent/CN103849638A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6492138B1 (en) * | 1998-05-21 | 2002-12-10 | Amgen Canada Inc. | Polynucleotides encoding a novel SHC-binding protein |
KR20010029353A (en) * | 1999-09-30 | 2001-04-06 | 최의주 | Rat SKIP protein and gene as a selective inhibitor of SAPK and as an apoptotic suppressor |
CN102061307A (en) * | 2010-11-23 | 2011-05-18 | 上海交通大学 | Construction method of yeast two-hybrid plasmids |
Non-Patent Citations (6)
Title |
---|
JENNIFER D LEWIS等: "Quantitative Interactor Screening with next-generation Sequencing (QIS-Seq) identifies Arabidopsis thaliana MLO2 as a target of the Pseudomonas syringae type III effector HopZ2", 《BMC GENOMICS》, 9 January 2012 (2012-01-09) * |
WALHOUT AJM等: "High-throughput yeast two-hybrid assays for large-scale protein interaction manning", 《METHODS》, 31 December 2001 (2001-12-31), pages 297 - 306 * |
ZHU T H等: "Construction of two Gateway vectors for gene expression in fungi", 《PLASMID》, 31 December 2009 (2009-12-31), pages 128 - 133 * |
崔晓艳等: "大豆花叶病毒诱导的应用于膜蛋白酵母双杂交的大豆cDNA 文库构建", 《植物病理学报》, 31 December 2013 (2013-12-31), pages 556 - 560 * |
邱爱连等: "Gateway 技术构建酵母双杂分析用辣椒cDNA文库", 《江西农业大学学报》, 31 December 2010 (2010-12-31), pages 0791 - 0796 * |
郭姗姗等: "基于Gateway技术的植物表达载体的构建", 《西北农林科技大学学报(自然科学版)》, 30 November 2010 (2010-11-30), pages 161 - 166 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745609A (en) * | 2015-03-20 | 2015-07-01 | 河南大学 | Method for high-flux rapidly cloning of rape draught-resistant gene |
CN110396515A (en) * | 2018-04-24 | 2019-11-01 | 上海欧易生物医学科技有限公司 | A kind of membranous system expression library reducing library redundancy and its construction method and application |
CN109680344A (en) * | 2018-12-19 | 2019-04-26 | 塔里木大学 | A kind of sheepskin skin tissue yeast cDNA library and its construction method |
CN114990105A (en) * | 2022-06-09 | 2022-09-02 | 南京瑞源生物技术有限公司 | Yeast membrane library construction method based on plant sample |
CN114990105B (en) * | 2022-06-09 | 2024-09-10 | 南京瑞源生物技术有限公司 | Yeast membrane library construction method based on plant sample |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220119871A1 (en) | In-situ spatial transcriptomics | |
CN107502608B (en) | Construction method and application of sgRNA for knocking out human ALDH2 gene and ALDH2 gene deletion cell line | |
CN107557378A (en) | Gene cas7 3 eukaryotic gene edit methods in a kind of type CRISPR Cas systems based on I | |
CN103849638A (en) | Plasmid vector for constructing and screening cDNA (complementary deoxyribonucleic acid) library and construction method and application of plasmid vector | |
CN108517360A (en) | A kind of circulating tumor dissociative DNA abrupt climatic change quality-control product and preparation method thereof | |
CN110066852A (en) | A kind of method and system detecting CRISPR/Cas PAM sequence in mammalian cells | |
CN106636154B (en) | sgRNA screening systems and methods | |
CN106947766A (en) | A kind of bacillus subtilis has DNA fragmentation and its application of promoter function | |
CN107091929B (en) | A kind of promoter batch catching method | |
CN106591954B (en) | A kind of easy, quickly, inexpensive Hi-C library constructing method | |
CN106086025A (en) | A kind of DNA fragmentation with promoter function and application thereof | |
CN106337053B (en) | Nucleic acid aptamer for detecting spring viremia of carp virus and application of nucleic acid aptamer | |
JP2007525982A5 (en) | ||
CN110004145B (en) | A kind of knockout method of sgRNA, knockout carrier, KLF4 gene and application thereof | |
CN104593393B (en) | Red forest ants AChE gene, red forest ants AChE and preparation method thereof | |
CN108754019B (en) | Amplification method of porcine epidemic diarrhea virus ORF1 gene complete sequence | |
CN101125874A (en) | Method and application of purifying small fragment DNA from gel by grinding method | |
CN108841991A (en) | Poplar chloroplast full-length genome PCR amplification primer and its application | |
CN106676117A (en) | Construction and authentication of newcastle disease virus overall-length cDNA clone | |
CN104388504A (en) | Method for preparing receptor-ligand binding sulfonamide antibiotic protein | |
CN114934096A (en) | Compositions and kits for performing immune repertoire sequencing and methods of sequencing | |
CN114276417A (en) | A method for identifying guanine quadruplex sites in genome-wide DNA under normal physiological conditions in plants | |
CN106754876A (en) | A kind of method that manilagrass cDNA library builds | |
CN102250941B (en) | Drug Screening Method Based on p16 Promoter | |
CN114410813B (en) | Method for identifying cytosine quadruplet site of plant genome DNA at whole genome level |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140611 |